Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prenatal betamethasone for prevention of neonatal respiratory morbidity before elective cesarean at 37-38+6 weeks
IRCT20120918010876N4Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of betamethasone in respiratory distress syndrome (RDS) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Need for CPAP or high-flow nasal cannula, Need for high-pressure oxygen and 10 more. Started Jul 2017; status: completed.
02
Drugs
betamethasone
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20120918010876N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120918010876N4.